82 related articles for article (PubMed ID: 23087795)
1. Single-center experience of patients with plasma cell leukemia in the era of new therapeutics.
Dampmann M; Flossdorf S; Keyl J; Reinhardt HC; Hanoun C
Acta Haematol; 2024 May; ():. PubMed ID: 38763126
[TBL] [Abstract][Full Text] [Related]
2. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Leukemia-Clinicopathological Profile from a Tertiary Care Center in Western India.
Manimaran P; Rai V; Ranka R; Sawhney J
South Asian J Cancer; 2023 Jul; 12(3):280-285. PubMed ID: 38047050
[TBL] [Abstract][Full Text] [Related]
4. A Rare Case of Primary Plasma Cell Leukaemia with Monosomy X.
Masamatti SS; Narasimha A; Shetty AC; Vijaya C
J Clin Diagn Res; 2017 Aug; 11(8):ED06-ED07. PubMed ID: 28969143
[TBL] [Abstract][Full Text] [Related]
5. Primary plasma cell leukemia: A case report and review of the literature.
Ngu S; Asti D; Valecha G; Thumallapally N; Pant M; Bershadskiy A
Clin Case Rep; 2019 Sep; 7(9):1702-1708. PubMed ID: 31534731
[TBL] [Abstract][Full Text] [Related]
6. Primary Plasma Cell Leukemia Revealed by a Mandibular Lesion: A Case Report.
Youssefi H; Ahnach M; Bendari M; Al Bouzidi A
Cureus; 2021 Dec; 13(12):e20148. PubMed ID: 35003980
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya.
Ong'ondi M; Kagotho E
Case Rep Hematol; 2021; 2021():4843818. PubMed ID: 34395001
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell leukaemia.
Braga CG; Rodrigues AR; Alves M; Portela C; Pinto L; Marques H
Porto Biomed J; 2016; 1(2):49-51. PubMed ID: 32258549
[TBL] [Abstract][Full Text] [Related]
9. Primary plasma cell leukemia presenting as a thoracic mass.
Igala M; Bopaka RG; Khtabi W; Benchekroun S; Quessar A
Pan Afr Med J; 2014; 19():39. PubMed ID: 25667701
[TBL] [Abstract][Full Text] [Related]
10. Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.
Gonsalves WI; Rajkumar SV; Go RS; Dispenzieri A; Gupta V; Singh PP; Buadi FK; Lacy MQ; Kapoor P; Dingli D; Lust JA; Zeldenrust SR; Hayman SR; Kyle RA; Gertz MA; Kumar SK
Blood; 2014 Aug; 124(6):907-12. PubMed ID: 24957143
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract][Full Text] [Related]
13. Primary Plasma Cell Leukemia: Identity Card 2016.
Musto P; Simeon V; Todoerti K; Neri A
Curr Treat Options Oncol; 2016 Apr; 17(4):19. PubMed ID: 26995215
[TBL] [Abstract][Full Text] [Related]
14. How I treat plasma cell leukemia.
van de Donk NW; Lokhorst HM; Anderson KC; Richardson PG
Blood; 2012 Sep; 120(12):2376-89. PubMed ID: 22837533
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.
Talamo G; Dolloff NG; Sharma K; Zhu J; Malysz J
Rare Tumors; 2012 Jun; 4(3):e39. PubMed ID: 23087795
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
Wang H; Zhou H; Zhang Z; Geng C; Chen W
Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
